Muhammad Aqib Faizan: New Evidence Supports Optimized Riociguat Use in Pulmonary Hypertension
Muhammad Aqib Faizan, Clinical Intern at District Headquarter Hospital, MTI, DIKhan, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Medicine, adding:
“Check out our systematic review and meta-analysis published in Medicine Journal.
Optimizing Riociguat Therapy for Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Dose Variability, Safety, and Efficacy
I’m proud to have led this collaborative international research effort focused on improving outcomes in patients with pulmonary hypertension.
Key Findings:
- Riociguat significantly improved 6-minute walk distance
- Reduced mean pulmonary arterial pressure
- Lowered pulmonary vascular resistance
- Decreased NT-proBNP levels
- The 2.5 mg three-times-daily dose showed the most consistent benefit
Our findings support personalized dosing strategies to optimize efficacy and safety in pulmonary hypertension management.
Grateful to all my co-authors and mentors for their dedication and teamwork throughout this journey.”
Title: Optimizing riociguat therapy for pulmonary hypertension: A systematic review and meta-analysis of dose variability, safety, and efficacy
Auhtors: Faizan Muhammad Aqib, Rehman Tooba, Malik Hurais, Hudaib Muhammad, Tahir Muhammad Abdullah, Ohri Gunvi, Bano Saher, Fatima Laveeza, Ahmed Syed Hassan, Karam Ayat ul, Ahmed Zuhair, Rehman Abdul, Rabbani Samra, Dandamudi Mrunalini, Mahmmoud Fadelallah Eljack Mohammed, Humayun Zainab

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support